Pj. Klingler et al., Indications, technical modalities and results of the duodenal switch operation for pathologic duodenogastric reflux, HEP-GASTRO, 46(25), 1999, pp. 97-102
BACKGROUND/AIMS: Reflux gastritis is caused by the excessive reflux of alka
line duodenal content into the stomach and can lead to intractable symptoms
. The main cause of pathologic duodenogastric reflux (DGR) is previous gast
ric surgery in which the pylorus is removed or rendered dysfunctional. The
entity of abnormal DGR without previous gastric surgery is called "primary
duodenogastric reflux". The main symptoms in these patients are severe uppe
r abdominal pain, nausea and bilious vomiting. DGR remains very difficult t
o diagnose and treat. Investigations include endoscopy with histological ex
amination, intragastric pH-monitoring, radionuclide scanning, gastric aspir
ation, antroduodenal manometry, and bile detection with special probes. Med
ical therapy is generally not helpful. Acid-blocking medications, sucralfat
e, prostaglandin E2 and cholestyramine used as an ion-exchange resin to bin
d bile salts do not usually improve symptoms. There is some evidence that u
rsodeoxycholate favorably affects symptoms but experience is limited.
METHODOLOGY: Surgical therapy was initially performed on selected patients
with intractable symptoms. A variety of operative procedures have been used
to treat pathologic DGR but cause significant side effects through changes
in the normal physiology of the foregut. DeMeester et al proposed a suprap
apillary duodenojejunostomy succinctly called the duodenal switch procedure
. It has been reported to maintain the integrity of the antro-pyloro-duoden
al mechanism with great patient satisfaction. Between 1984 and 1995, 32 pat
ients (9 men and 23 women), mean age 50 years (range: 30-77), required panc
reaticobiliary diversion using the switch procedure for symptomatic gastrit
is related to abnormal primary DGR. Symptoms were evaluated with a symptom
score using a detailed questionnaire.
RESULTS: After a mean follow-up of 4 years (n=32, range: 0.5-8.2), 94% of t
he patients had a good clinical outcome as defined by a significant reducti
on in pre-operative symptoms. There was no mortality.
CONCLUSIONS: Suprapapillary Roux-en-Y duodenojejunostomy (duodenal switch p
rocedure) is an effective surgical therapy in patients with pathologic prim
ary DGR.